Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
58.9M
-
Number of holders
-
182
-
Total 13F shares, excl. options
-
54.5M
-
Shares change
-
-425K
-
Total reported value, excl. options
-
$820M
-
Value change
-
-$4.49M
-
Put/Call ratio
-
1.02
-
Number of buys
-
97
-
Number of sells
-
-80
-
Price
-
$15.02
Significant Holders of Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share (VNDA) as of Q1 2021
204 filings reported holding VNDA - Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share as of Q1 2021.
Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share (VNDA) has 182 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 54.5M shares
of 58.9M outstanding shares and own 92.64% of the company stock.
Largest 10 shareholders include BlackRock Inc. (10M shares), VANGUARD GROUP INC (4.04M shares), ARMISTICE CAPITAL, LLC (3.8M shares), Palo Alto Investors LP (3.79M shares), RENAISSANCE TECHNOLOGIES LLC (3.69M shares), STATE STREET CORP (3.31M shares), MACQUARIE GROUP LTD (3.15M shares), DIMENSIONAL FUND ADVISORS LP (1.73M shares), LSV ASSET MANAGEMENT (1.32M shares), and Epoch Investment Partners, Inc. (1.16M shares).
This table shows the top 182 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.